ONCAlert | Upfront Therapy for mRCC
News
EU Approves Olaparib as Frontline Maintenance for BRCA+ Ovarian Cancer
9:13 PM, Wed June 19, 2019
Analyzing Best Practices for Targeting EGFR Resistance Mutations in EGFR+ NSCLC
1:04 PM, Wed June 19, 2019
Frontline EGFR TKI Combination Reduces Risk of Progression or Death in EGFR+ NSCLC
9:00 PM, Tue June 18, 2019
PFS and EFS Extended With Ibrutinib Monotherapy in Early-Stage CLL
4:18 PM, Tue June 18, 2019
Konduri Considers Alternatives to Surgical Resection in a Patient With Stage III NSCLC
4:17 PM, Tue June 18, 2019
Pembrolizumab Approved by FDA for Previously Treated Metastatic SCLC
12:22 PM, Tue June 18, 2019
Transfusion Independence in Relapsed/Refractory MDS May Be Possible With Imetelstat
8:42 PM, Mon June 17, 2019
Bevacizumab Added to CAPIRI Shown to be Safe and Effective in Metastatic CRC
5:28 PM, Mon June 17, 2019
